WHO ICTRP trial
Pyridoxamine for menopausal disorder
JPRN-jRCTs031220256 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCTs031220256 |
|---|---|
| Public title | Pyridoxamine for menopausal disorder |
| Scientific title | Explorative study on the effects of pyridoxamine in patients with menopausal disorder with psychological symptoms |
| Primary sponsor | Terauchi Masakazu |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 2-3 |
| Conditions | menopausal disorder with psychological symptoms |
| Interventions | After informed consent is obtained, patients are registered provisionally, and are orally administered 2 placebo capsules a day, each after breakfast and supper, for 2 weeks. Those who did not respond to the placebo capsules are definitely… |
| Registration date | Aug 8, 2022 |
| Target size | 50 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: